Altered cardiovascular vagal responses in nonelderly female patients with subclinical hyperthyroidism and no apparent cardiovascular disease

Clinical Endocrinology

Volumn 67, Issue 2, 2007, Pages 290-294

  Portella, Renata Boschi ^a,b   Pedrosa, Roberto Coury ^a   Coeli, Claudia Medina ^a   Buescu, Alexandru ^a   Vaisman, Mario ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC STIMULATION; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DATA ANALYSIS; ELECTROCARDIOGRAPHY; FEMALE; FREE THYROXINE INDEX; HEART RATE VARIABILITY; HUMAN; HYPERTHYROIDISM; PRIORITY JOURNAL; REST; SINUS ARRHYTHMIA; THYROTROPIN BLOOD LEVEL; TILTING; VAGUS NERVE STIMULATION; VAGUS TONE;

ADULT; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR SYSTEM; CROSS-SECTIONAL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HUMANS; HYPERTHYROIDISM; MIDDLE AGED; THYROTROPIN; THYROXINE; TILT-TABLE TEST; VAGUS NERVE;

EID: 34447525164     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02879.x     Document Type: Article

References (40)

1. Col, N.F., Surks, M.I. Daniels, G.H. (2004) Subclinical thyroid disease: clinical applications. Journal of the American Medical Association, 291, 239 243.
2. Helfand, M. (2004) Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 140, 128 141.
3. Braverman, L.E. Pearce, E.N. (2002) Hipertireoidismo subclínico. Thyroid International, 2, 3 12.
4. McDermott, M.T., Woodmansee, W.W., Haugen, B.R., Smart, A. Ridgway, E.C. (2003) The management of subclinical hyperthyroidism by thyroid specialists. Thyroid, 13, 1133 1139.
5. Sawin, C.T., Geller, A., Wolf, P.A., Belanger, A.J., Baker, E., Bacharat, P., Wilson, P.W.F., Benjamin, E.J. D'Agostino, R.B. (1994) Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. New England Journal of Medicine, 331, 1249 1252.
6. Cappola, A.R., Fried, L.P., Arnold, A.M., Danese, M.D., Kuller, L.H., Burke, G.L., Tracy, R.P. Ladenson, P.W. (2006) Thyroid status, cardiovascular risk, and mortality in older adults. Journal of the American Medical Association, 295, 1033 1041.
7. Parle, J.V., Maisonneuve, P., Sheppard, M.C., Boyle, P. Franklyn, J.A. (2001) Prediction of all-cause mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. The Lancet, 358, 861 865.
8. Franklyn, J.A., Sheppard, M.C. Maisonneuve, P. (2005) Thyroid function and mortality in patients treated for hyperthyroidism. Journal of the American Medical Association, 294, 71 80.
9. Dörr, M., Wolff, B., Robinson, D.M., John, U., Lüdemann, J., Meng, W., Felix, S.B. Völzke, H. (2005) The association of thyroid function with cardiac mass and left ventricular hypertrophy. Journal of Clinical Endocrinology and Metabolism, 90, 673 677.
10. Biondi, B., Fazio, S., Carella, C., Amato, G., Cittadini, A., Lupoli, G., Saccà, L., Bellastella, A. Lombardi, G. (1993) Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. Journal of Clinical Endocrinology and Metabolism, 77, 334 338.
11. Fazio, S., Biondi, B., Carella, C., Sabatini, D., Cittadini, A., Panza, N., Lombardi, G. Saccà, L. (1995) Diastolic dysfunction in patients on thyroid-stimulating hormone suppressive therapy with levothyroxine: beneficial effect of β-blockade. Journal of Clinical Endocrinology and Metabolism, 80, 2222 2226.
12. Biondi, B., Palmieri, E.A., Fazio, S., Cosco, C., Nocera, M., Saccà, L., Filetti, S., Lombardi, G. Perticone, F. (2000) Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. Journal of Clinical Endocrinology and Metabolism, 85, 4701 4705.
13. Mercuro, G., Panzuto, M.G., Bina, A., Leo, M., Cabula, R., Petrini, L., Pigliaru, F. Mariotti, S. (2000) Cardiac function, physical exercise capacity and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring. Journal of Clinical Endocrinology and Metabolism, 85, 159 164.
14. Sgarbi, J.A., Villaça, F.G., Garbeline, B., Villar, H.E. Romaldini, J.H. (2003) The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities. Journal of Clinical Endocrinology and Metabolism, 88, 1672 1677.
15. Biondi, B., Fazio, S., Cuocolo, A., Sabatini, D., Nicolai, E., Lombardi, G., Salvatore, M. Saccà, L. (1996) Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine. Journal of Clinical Endocrinology and Metabolism, 81, 4224 4228.
16. Völzke, H., Robinson, D.M., Schminke, U., Lüdemann, J., Rettig, R., Felix, S.B., Kessler, C., John, U. Meng, W. (2004) Thyroid function and carotid wall thickness. Journal of Clinical Endocrinology and Metabolism, 89, 2145 2149.
17. Faber, J., Wiinberg, N., Schifter, S. Mehlsen, J. (2001) Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. European Journal of Endocrinology, 145, 391 396.
18. Petretta, M., Bonaduce, D., Spinelli, L., Vicario, M.L.E., Nuzzo, V., Marciano, F., Camuso, P., De Sanctis, V. Lupoli, G. (2001) Cardiovascular haemodynamics and cardiac autonomic control in patients with subclinical and overt hyperthyroidism. European Journal of Endocrinology, 145, 691 696.
19. Goichot, B., Brandenberger, G., Vinzio, S., Perrin, A.E., Geny, B., Schlienger, J.L. Simon, C. (2004) Sympathovagal response to orthostatism in overt and in subclinical hyperthyroidism. Journal of Endocrinological Investigations, 27, 348 352.
20. Osman, F., Franklyn, J.A., Daykin, J., Chowdhary, S., Holder, R.L., Sheppard, M.C. Gammage, M.D. (2004) Heart rate variability and turbulence in hyperthyroidism before, during and after treatment. The American Journal of Cardiology, 94, 465 469.
21. Shapiro, L.E., Sievert, R., Ong, L., Ocampo, E.L., Chance, R.A., Lee, M., Nanna, M., Ferrick, K. Surks, M.L. (1997) Minimal cardiac effects in asymptomatic athyreotic patients chronically treated with thyrotropin- suppressive doses of 1-thyroxine. Journal of Clinical Endocrinology and Metabolism, 82, 2592 2595.
22. Portella, R.B., Silva, J.L., Wagman, M.B., Oliveira, F.P., Buescu, A. Vaisman, M. (2006) Exercise performance in young and middle-aged female patients with subclinical hyperthyroidism. Thyroid, 16, 731 735.
23. Olshansky, B. (2005) Interrelationships between the autonomic nervous system and atrial fibrillation. Progress in Cardiovascular Diseases, 48, 57 78.
24. Levey, G.S. (1990) Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. The American Journal of Medicine, 88, 642 646.
25. Coulombe, P., Dussault, J.H., Letarte, J. Simard, S.J. (1974) Catecholamines metabolism in thyroid diseases. I. Epinefrine secretion rate in hyperthyroidism and hypothyroidism. Journal of Clinical Endocrinology and Metabolism, 42, 125 131.
26. Burggraaf, J., Tulen, J.H.M., Lalezari, S., Schoemaker, R.C., De Meyer, P.H.E.M., Meinders, A.E., Cohen, A.F. Pijl, H. (2001) Sympathovagal imbalance in hyperthyroidism. American Journal of Physiology - Endocrinology and Metabolism, 281, E190 E195.
27. Bigger, J.T., Fleiss, J.L. Steinman, R.C. (1992) Correlations among time and frequency domain measures of heart period variability two weeks after myocardial infarction. The American Journal of Cardiology, 69, 891 898.
28. Nolan, J., Flapan, A.D., Goodfield, N.E., Prescott, R.J., Bloomfield, P., Neilson, J.M. Ewing, D.J. (1996) Measurement of parasympathetic activity from 24-hours ambulatory electrocardiograms and its reproducibility and sensitivity in normal subjects, patients with symptomatic myocardial ischemia, and patients with diabetes mellitus. The American Journal of Cardiology, 77, 154 158.
29. Task Force of the European Society of Cardiology the North American Society of Pacing Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation, 93, 1043 1065.
30. American College of Sport Medicine (2000) ACSM's guidelines for exercise testing and prescription, 6th edn. Lippincott Williams & Wilkins, Philadelphia, PA.
31. Barbosa, P.R.B., Barbosa Filho, J., Cordovil, I., Medeiros, A.B. Nadal, J. (2000) Phase response of the spectral coherence between heart rate variability and ventricular repolarization duration in normal subjects. Computers in Cardiology, 27, 159 162.
32. Barbosa Filho, J., Barbosa, P.R. Cordovil, I. (2002) Autonomic modulation of the heart in systemic arterial hypertension. Arquivos Brasileiros de Cardiologia, 78, 181 195.
33. Bittencourt, M.I., Barbosa, P.R., Drumond Neto, C., Bedirian, R., Barbosa, E.C., Brasil, F., Bonfim Ade, S. Albanesi Filho, F.M. (2005) Assessing autonomic function in hypertrophic cardiomyopathy. Arquivos Brasileiros de Cardiologia, 85, 388 396.
34. Bainbridge, F.A. (1920) The relation between respiration and the pulse-rate. Journal of Physiology, London, 54, 192 202.
35. Baldwa, V.S. Ewing, D.J. (1977) Heart rate response to Valsalva maneuver: reproducibility in normals and relation to variation in resting heart rate in diabetics. British Heart Journal, 39, 641 644.
36. Wieling, W., Borst, C., Karemaker, J.M. Dunning, A.J. (1985) Testing for autonomic neuropathy: initial heart rate response to active and passive changes of posture. Clinical Physiology, 5 (Suppl. 23 27.
37. Kleiger, R.E. Bornes, M.S. (1996) Correlation of time and frequency-domain measures of heart rate variability. In : A. Moss, S. Stern eds. Noninvasive Electrocardiology - Clinical Aspects of Holter Monitoring. W.B. Saunders Company Ltd, London, 199 206.
38. Bryant, T.N. (2000) CIA - confidence interval analysis for Windows, version 2.1.2. Available at: http://www.medschool.soton.ac.uk/cia/ (accessed 1 May 2007).
39. Campbell, M.J. Gardner, M.J. (2000) Medians and their differences. In : D.G. Altman, D. Machin, T.N. Bryant, M.J. Gardner eds. Statistics with Confidence. BMJ Books, London, 34 36.
40. Ching, G.W., Franklyn, J.A., Stallard, T.J., Daykin, J., Sheppard, M.C. Gammage, M.D. (1996) Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. Heart, 75, 363 368.